Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Aging Clin Exp Res ; 34(2): 383-389, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34213747

RESUMEN

BACKGROUND: During the walk along the streets, older adults are exposed to various visual stimuli that can affect their gait in a harmful or beneficial way. AIMS: To evaluate gait strategies during different situations with and without visual stimulation in older adults to identify the influence of the visual stimulus on these gait parameters. METHODS: A total of 200 older adults were divided into 4 groups according to age range between 60 and 102 years. Gait was evaluated in the following situations: (1) habitual gait (HG); (2) gait with the visual stimulation (GVS) provided by a pedestrian traffic light, and (3) GVS associated with a cognitive task (GVS-C). The GAITRite Platinum equipment was used to assess gait variables. RESULTS: Comparison of GVS and HG revealed that the visual stimulus influences the gait parameters and promotes a gait speed increase. However, to increase their gait speed, older adults aged 60-89 years used strategies of increased step length and cadence, whereas subjects older than 90 years used only strategies of increased cadence. In addition, comparison of GVS and GVS-C revealed a decrease in gait speed in all age ranges when the cognitive task was added, although this reduction was more pronounced in subjects older than 70 years. CONCLUSION: Visual stimulus influences the gait parameters in older adults and the strategy used is different depending on their age, a fact that shows that traffic light may be an interesting strategy to improve the gait performance during physical therapy.


Asunto(s)
Marcha , Terapia Ocupacional , Anciano , Anciano de 80 o más Años , Cognición , Humanos , Estimulación Luminosa , Caminata , Velocidad al Caminar
2.
Women Health ; 61(4): 372-380, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33726633

RESUMEN

The objective of this study was to compare the functional performance of community-dwelling older adults of both sexes and investigate the possible mediation aspects that may influence the sex differences regarding socioeconomic and anthropometric characteristics, health status, and quadriceps muscle strength. 233 Brazilian older adults were assessed, and men's and women's sociodemographic data, physical activity level, quadriceps muscle strength, functional performance (gait speed and the SPPB), and history of falls were compared. Sex differences in functional performance were observed even after statistically adjusting the model (age, body mass, income, physical activity level, and occurrence of falls). When quadriceps muscle strength was included in the adjusted model, the sex difference remained only for gait speed. When stature was included in the adjusted model, the sex difference in gait speed disappeared. Our results suggest that the sex difference in functional performance assessed by the SPPB can be explained due to the fact that men are stronger than women. In addition, the sex difference regarding gait speed was explained by the sex difference in stature. Public actions that encourage older women to practice physical activities that promote increased muscle strength can positively interfere with their best functional performance for as long as possible.


Asunto(s)
Marcha , Rendimiento Físico Funcional , Anciano , Femenino , Humanos , Vida Independiente , Masculino , Fuerza Muscular , Velocidad al Caminar
3.
Physiotherapy ; 110: 63-69, 2021 03.
Artículo en Inglés | MEDLINE | ID: mdl-32349866

RESUMEN

OBJECTIVES: To assess the Balance Evaluation Systems Test (BESTest), Mini-Balance Evaluation Systems Test (Mini-BESTest), Timed Up and Go (TUG) test and gait speed to determine which is the most appropriate test for identification of adults aged ≥80 years at higher risk of falls, and to investigate the clinical usefulness of the combination of such tests by cumulative post-test probability (PoTP) for predicting the risk of falls. DESIGN: Longitudinal prospective study. PARTICIPANTS: Ninety-eight older adults (aged 80-102 years). INTERVENTIONS: Older adults were submitted to the clinical tests and followed-up in order to record the occurrence of falls. The capacity of the clinical tests to detect which older adults are at higher risk of falls was measured using the receiver operating characteristic curve, followed by calculation of PoTP for predicting the risk of falls. RESULTS: The BESTest and the Mini-BESTest demonstrated the best PoTP for predicting the risk of falls for a positive test (70%), followed by the TUG test (66%) and gait speed (63%). When performed in combination, a positive result on the TUG test, gait speed and Mini-BESTest increased the probability of older adults falling within the next 6months from 50% to 89%; a negative result on these three tests decreased the probability of older adults falling within the next 6months from 50% to 3%. CONCLUSION: The combination of TUG test, gait speed and Mini-BESTest provided the best approach. If all three tests are positive, there is an 89% chance of identifying an older person at risk of falling. If all three tests are negative, there would only be a 3% chance of obtaining a false-negative result.


Asunto(s)
Accidentes por Caídas , Evaluación Geriátrica/métodos , Medición de Riesgo/métodos , Anciano de 80 o más Años , Envejecimiento , Femenino , Humanos , Estudios Longitudinales , Masculino , Valor Predictivo de las Pruebas , Estudios Prospectivos , Curva ROC
4.
J Geriatr Phys Ther ; 43(4): 179-184, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31162155

RESUMEN

BACKGROUND AND PURPOSE: Reference values for the Balance Evaluation Systems Test (BESTest) and the Mini-Balance Evaluation Systems Test (Mini-BESTest) need to be established to predict falls in older adults during every stage of aging. The purpose of this study was to determine the cutoff scores for the BESTest and the Mini-BESTest for community-dwelling older adults in order to predict fall risk. METHODS: A total of 264 older adults, of both sexes, between the ages of 60 and 102 years, were divided into 4 groups according to age range. After evaluation, participants received telephone follow-up for 6 months to record the number of fall episodes. To define the reference values of the tests in relation to fall risk prediction, a receiver operating characteristic curve was drawn to identify the area under the curve and the sensitivity and specificity of the tests. Statistical analyses were done using SPSS (Version 16.0-SPSS Inc) with a significance level of 5% (P ≤ .05). RESULTS: The cutoff scores to identify older adults with fall risk according to the BESTest and the Mini-BESTest in the different age groups were 99 and 25 points, respectively, for people 60 to 69 years of age, 92 and 23 points for the age group of 70 to 79 years, 85 and 22 points for people 80 to 89 years of age, and 74 and 17 points for people 90 years of age or older. CONCLUSION: The BESTest and the Mini-BESTest are good tools for predicting fall risk in the 6 months following an initial evaluation in community-dwelling Brazilian older adults. The study also determined that cutoff values vary for different age groups.


Asunto(s)
Accidentes por Caídas , Medición de Riesgo , Anciano , Anciano de 80 o más Años , Brasil , Evaluación de la Discapacidad , Femenino , Predicción , Humanos , Vida Independiente , Masculino , Modalidades de Fisioterapia , Equilibrio Postural , Psicometría , Curva ROC , Reproducibilidad de los Resultados
5.
Hum Mov Sci ; 68: 102540, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31683084

RESUMEN

BACKGROUND: With increases in life expectancy, it is important to understand the influence of aging on gait, given that this activity is related to the independence of older adults and may help in the development of health strategies that encourage successful aging in all phases of this process. RESEARCH QUESTION: To compare gait parameters with usual and fast speeds for independent and autonomous older adults throughout the aging process (60 to 102 years old), and also to identify which of the gait variables are best for identifying differences across the different age groups. METHODS: Two hundred older adults aged between 60 and 102 years were evaluated. The sample was divided into 3 age groups: 60 to 79 years, 80 to 89 years and 90 years and over. The analyzed gait variables were: speed (meters/s), cadence (steps/min), stride time (seconds), step length (centimeters), double support (percentage of the gait cycle), swing (percentage of the gait cycle), step length variability (CoV%) and stride time variability (CoV%). RESULTS: Group comparison regarding usual gait and fast gait revealed a significant difference in all gait variables. In addition, it can be seen that variables such as gait speed and step length showed greater effect sizes in intergroup comparison (usual gait: 0.48 and 0.47; fast gait: 0.36 and 0.40; respectively), possibly showing that these variables can better detect the changes observed with increasing age. CONCLUSION: There are differences in the gait performance of older adults from different age groups for usual and fast gait speeds, which is more evident regarding gait speed and step length variables. We recommend the use of usual gait for the identification of the effects of aging because, besides showing a higher effect size values it is more comfortable and requires less effort from older subjects.


Asunto(s)
Envejecimiento/fisiología , Marcha/fisiología , Anciano , Anciano de 80 o más Años , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Velocidad al Caminar/fisiología
6.
Acta Ortop Bras ; 25(4): 147-150, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28955171

RESUMEN

OBJECTIVE: The aim of this study was to evaluate functional independence and trunk control during maximum-range tasks in individuals with spinal cord injuries, who were divided into sedentary (SSI, n=10) and physically active (PASI, n=10) groups . METHODS: Anamnesis was conducted and level and type of injury were identified (according to the American Spinal Injury Association protocol, ASIA) and the Functional Independence Measure (FIM) questionnaire was applied. For the forward and lateral reach task, the subjects were instructed to reach as far as possible. Mean data were compared using the unpaired t test and Mann-Whitney test and differences were considered significant when p<0.05 . RESULTS: The PASI group performed better in self-care activities (PASI: 40.8±0.42 points, SSI: 38.0±3.58 points, p=0.01), sphincter control (PASI: 10.5±1.84 points, SSI: 8.2±3.04 points, p=0.02), transfers (PASI: 20.7±0.48 points, SSI: 16.9±4.27 points, p=0.04), and total FIM score (PASI: 104.0±2.30 points, SSI 105.1±8.56 points, p=0.01). On the maximum reach task, the PASI group had a greater average range in all directions evaluated (p<0.05) . CONCLUSION: The continuous practice of exercise increased motor function independence and trunk control in individuals with complete spinal cord injury. Level of Evidence II, Prospective Comparative Study.


OBJETIVO: O objetivo deste estudo foi avaliar a independência funcional e o controle de tronco durante tarefas de alcance máximo em indivíduos com lesão medular, que foram divididos em grupo sedentário (SSI, n = 10) e grupo fisicamente ativo (PASI, n=10). MÉTODOS: Foi realizada anamnese, identificação do nível e tipo de lesão (de acordo com o protocolo da ASIA - American Spinal Injury Association), e aplicou-se o questionário de Medida de Independência Funcional (MIF). Para a tarefa de alcance anterior e lateral os indivíduos foram instruídos a fazer o alcance máximo. Para comparação das médias dos dados foram aplicados o teste t não pareado e teste de Mann-Whitney, e as diferenças foram consideradas significativas quando p < 0,05. RESULTADOS: O grupo PASI teve melhor desempenho na realização de atividades de autocuidado (PASI: 40,8 ± 0,42 pontos, SSI 38,0 ± 3,58 pontos, p = 0,01), controle de esfíncter (PASI: 10,5 ± 1,84 pontos, SSI 8,2 ± 3,04 pontos, p = 0,02), transferências (PASI: 20,7 ± 0,48 pontos, SSI 16,9 ± 4,27 pontos, p = 0,04) e MIF total (PASI: 104,0 ± 2,30 pontos, SSI 105,1 ± 8,56 pontos, p = 0,01). No alcance máximo, o grupo PASI teve maior alcance médio em todas as direções avaliadas (p < 0,05) . CONCLUSÃO: A prática de exercício físico contínuo aumentou a independência funcional motora e o controle de tronco em indivíduos com lesão medular completa. Nível de Evidência II, Estudo Prospectivo Comparativo.

7.
Hum Mov Sci ; 51: 146-152, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28038330

RESUMEN

Human gait has been widely investigated under dual-task conditions because it has been demonstrated to be an important way to uncover differences in gait biomechanics between older fallers and non-fallers. However, exactly how simultaneous tasks affect the kinematics of walking remains unclear. In the present study, gait kinematic properties of older fallers and non-fallers were compared under cognitive and motor dual-task conditions. The gait kinematic properties of interest were recorded under three different conditions: walking at preferred speed, walking when performing a cognitive task (naming animals), and walking when performing a motor task (transferring a coin from one pocket to the other). The following variables were analyzed: gait speed, cadence, stride time, step length, single support, stride time variability, and the dual-task cost. In addition, functional balance was evaluated by means of the Balance Evaluation - Systems Test (BESTest). Two-way repeated-measures ANOVAs revealed significant main effects of walking conditions. However, no significant main effects of group (fallers vs. non-fallers) and no significant interaction effects between group and walking condition were observed. The BESTest revealed that functional balance in fallers was worse than in non-fallers. The cognitive task leads to more significant changes in gait kinematics than does a motor task and the step length and stride time variability were variables more sensitive to that cognitive influence.


Asunto(s)
Accidentes por Caídas , Atención/fisiología , Fenómenos Biomecánicos/fisiología , Marcha/fisiología , Recuerdo Mental/fisiología , Solución de Problemas/fisiología , Caminata/fisiología , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Velocidad al Caminar/fisiología
8.
Eur J Obstet Gynecol Reprod Biol ; 117(1): 70-5, 2004 Nov 10.
Artículo en Inglés | MEDLINE | ID: mdl-15474248

RESUMEN

METHODS: This was a randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of Vitamin C vaginal tablets (250 mg) given once a day in patients suffering from non-specific vaginitis. The total length of the study was 20 days, including a treatment phase of 6 days. The primary end-point was the presence in the two groups of non-specific vaginitis 1 and 2 weeks after the end of treatment, as assessed by at least 3 out of the 4 characteristic symptoms: discharge, fishy odour, vaginal pH >/= 4.7, and presence of clue cells. Secondary end-points were the individual symptoms and signs, above reported, and pruritus, fever, superinfections, microscopic findings on vaginal smear, and colposcopy. PATIENTS: One hundred female patients aged 18 years or older and suffering from non-specific vaginitis were included in the study after giving their informed consent. Fifty were randomised to the active treatment and 50 to placebo. Seven patients, three in the Vitamin C group and four in the placebo group, were lost to follow-up and did not complete the treatment period. Two patients in the active group showed protocol deviations (age under 18 years and HIV-positive, respectively). The two groups resulted comparable for demographics, history and baseline clinical picture. RESULTS: A cluster analysis of the four main symptoms showed a statistically significant difference between the active group and the placebo group; significantly more patients were still affected by non-specific vaginitis after placebo (35.7%) compared to patients treated with Vitamin C tablets (14.0%). The meaningful secondary variable, referring to the microscopic examination of vaginal smear, supported the trend for efficacy in the Vitamin C treated group. The clue cells disappeared in 79% of patients treated with the drug and in 53% of patients on placebo. Similarly, bacteria disappeared in 77 and 54%, respectively, while lactobacilli reappeared in 79.1 and 53.3%, respectively. Vaginal pH values decreased significantly in both groups, but the frequency rate of subjects with pH >/= 4.7, as measured 1 week after the drug discontinuation, was significantly lesser in the Vitamin C group (16.3%) than in the placebo group (38.6%). Adverse events occurred in four patients, two on placebo (pruritus, cystitis) and two on Vitamin C (two candidiasis).


Asunto(s)
Antioxidantes/uso terapéutico , Ácido Ascórbico/uso terapéutico , Vaginitis/tratamiento farmacológico , Administración Intravaginal , Adulto , Antioxidantes/efectos adversos , Ácido Ascórbico/efectos adversos , Método Doble Ciego , Femenino , Humanos , Efecto Placebo , Seguridad , Comprimidos , Resultado del Tratamiento , Cremas, Espumas y Geles Vaginales/administración & dosificación
9.
Acta ortop. bras ; 25(4): 147-150, July-Aug. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-886481

RESUMEN

ABSTRACT Objective: The aim of this study was to evaluate functional independence and trunk control during maximum-range tasks in individuals with spinal cord injuries, who were divided into sedentary (SSI, n=10) and physically active (PASI, n=10) groups . Methods: Anamnesis was conducted and level and type of injury were identified (according to the American Spinal Injury Association protocol, ASIA) and the Functional Independence Measure (FIM) questionnaire was applied. For the forward and lateral reach task, the subjects were instructed to reach as far as possible. Mean data were compared using the unpaired t test and Mann-Whitney test and differences were considered significant when p<0.05 . Results: The PASI group performed better in self-care activities (PASI: 40.8±0.42 points, SSI: 38.0±3.58 points, p=0.01), sphincter control (PASI: 10.5±1.84 points, SSI: 8.2±3.04 points, p=0.02), transfers (PASI: 20.7±0.48 points, SSI: 16.9±4.27 points, p=0.04), and total FIM score (PASI: 104.0±2.30 points, SSI 105.1±8.56 points, p=0.01). On the maximum reach task, the PASI group had a greater average range in all directions evaluated (p<0.05) . Conclusion: The continuous practice of exercise increased motor function independence and trunk control in individuals with complete spinal cord injury. Level of Evidence II, Prospective Comparative Study.


RESUMO Objetivo: O objetivo deste estudo foi avaliar a independência funcional e o controle de tronco durante tarefas de alcance máximo em indivíduos com lesão medular, que foram divididos em grupo sedentário (SSI, n = 10) e grupo fisicamente ativo (PASI, n=10). Métodos: Foi realizada anamnese, identificação do nível e tipo de lesão (de acordo com o protocolo da ASIA - American Spinal Injury Association), e aplicou-se o questionário de Medida de Independência Funcional (MIF). Para a tarefa de alcance anterior e lateral os indivíduos foram instruídos a fazer o alcance máximo. Para comparação das médias dos dados foram aplicados o teste t não pareado e teste de Mann-Whitney, e as diferenças foram consideradas significativas quando p < 0,05. Resultados: O grupo PASI teve melhor desempenho na realização de atividades de autocuidado (PASI: 40,8 ± 0,42 pontos, SSI 38,0 ± 3,58 pontos, p = 0,01), controle de esfíncter (PASI: 10,5 ± 1,84 pontos, SSI 8,2 ± 3,04 pontos, p = 0,02), transferências (PASI: 20,7 ± 0,48 pontos, SSI 16,9 ± 4,27 pontos, p = 0,04) e MIF total (PASI: 104,0 ± 2,30 pontos, SSI 105,1 ± 8,56 pontos, p = 0,01). No alcance máximo, o grupo PASI teve maior alcance médio em todas as direções avaliadas (p < 0,05) . Conclusão: A prática de exercício físico contínuo aumentou a independência funcional motora e o controle de tronco em indivíduos com lesão medular completa. Nível de Evidência II, Estudo Prospectivo Comparativo.

10.
Gynecol Endocrinol ; 22(4): 230-4, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16723311

RESUMEN

The primary objective of this randomized, double-blind, controlled study was the assessment of the pH-lowering effect of three different formulations of a vaginal device each containing 250 mg vitamin C. Overall, 39 women with vaginal pH >or=5, without evidence of vaginal infections, were randomly assigned to receive one of the three formulations for 6 days. The primary parameter assessed was vaginal pH, performed by the physician at the baseline and final visits and by the subjects each day during the application period; secondary parameters included the acceptability and safety profile of the tested devices. A decrease in pH to the normal range in all groups was observed following the first application, with stable low values during the whole study period. No statistically significant differences were seen among the three groups, while statistically significant within-group differences were observed. Acceptability and tolerability were rated as very good/good in most cases. The study results confirm that the vaginal application of vitamin C has an effective and long-lasting vaginal pH-lowering effect.


Asunto(s)
Ácido Ascórbico/administración & dosificación , Vagina/química , Vagina/efectos de los fármacos , Administración Intravaginal , Análisis de Varianza , Ácido Ascórbico/efectos adversos , Distribución de Chi-Cuadrado , Método Doble Ciego , Composición de Medicamentos/métodos , Femenino , Humanos , Concentración de Iones de Hidrógeno/efectos de los fármacos , Persona de Mediana Edad , Resultado del Tratamiento , Cremas, Espumas y Geles Vaginales/administración & dosificación , Cremas, Espumas y Geles Vaginales/efectos adversos
11.
Arzneimittelforschung ; 56(3): 230-8, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16618016

RESUMEN

Menopause is often associated with vaginal atrophy and related symptoms, such as vaginal dryness, burning, itching, and dyspareunia, decrease in libido and in general a decrease in the quality of life. The common treatment up to the 1990's has been the oral hormone replacement therapy (HRT), but this treatment has been consequently re-considered due to its adverse effects. Topical estrogenic products have been subsequently developed to minimize the systemic adverse effects of the oral HRT, but they are still considered at risk in case of prolonged use. As an alternative, two clinical trials were performed to investigate the effects of a medical device in the form of a gel, containing hyaluronic acid, liposomes, phytoestrogens from Humulus lupulus extract, and Vitamin E, with the aim of testing its safety and efficacy in post-menopausal women with urogenital atrophy. The first pilot study confirmed in 10 women the good safety profile, both locally and systemically, of the device applied on the external genitals at the dose of 1-2 g/day for 30 days. The second study was carried out, according to a multicenter, open, non-controlled design, in 100 post-menopausal women assigned to the vaginal application of 2.5 g of gel/day for 1 week followed by two applications/week for 11 weeks. The primary end-point was the evaluation of vaginal dryness assessed by a Visual Analogue Scale both by the investigator and the subject. Secondary endpoints were the evaluation of all other symptoms and signs associated with atrophic vaginitis (itching, burning, dyspareunia, vaginal inflammation/oedema and rash assessed by a 4-point scale and presence of vaginal abrasions and disepithelialisation), and the recording of adverse events during the study. At the end of the treatment, an overall judgment on the efficacy and safety of the device was made by the investigator and a judgment on the acceptability of the treatment was made by the subjects. The results showed a marked effect of the tested product on the vaginal dryness and on all other symptoms and signs with statistically significant reductions since the first week of treatment. No treatment-related adverse events were complained by the subjects and the treatment course showed a high level of acceptability by the subjects. This device could be considered an effective and safe alternative treatment of genital atrophy in post-menopausal women, especially when HRT is not recommended.


Asunto(s)
Equipos y Suministros , Posmenopausia/fisiología , Enfermedades Vaginales/prevención & control , Administración Intravaginal , Administración Tópica , Anciano , Antioxidantes/administración & dosificación , Antioxidantes/uso terapéutico , Atrofia , Elasticidad , Determinación de Punto Final , Terapia de Reemplazo de Estrógeno , Femenino , Geles , Humanos , Humulus/química , Ácido Hialurónico/administración & dosificación , Liposomas , Lubrificación , Persona de Mediana Edad , Fitoestrógenos/administración & dosificación , Fitoestrógenos/uso terapéutico , Proyectos Piloto , Enfermedades Vaginales/patología , Vitamina E/administración & dosificación , Vitamina E/uso terapéutico
12.
Arzneimittelforschung ; 54(10): 647-54, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15553103

RESUMEN

The trial was designed as an open-label, post-authorisation safety study, aimed to complete the available information on adverse events and drug reactions to alpha-dihydroergocryptine (CAS 14271-05-7, alpha-DHEC). The study included 294 patients with idiopathic Parkinson's disease who received levodopa (CAS 59-92-7, L-DOPA) and started taking alpha-DHEC (Cripar). Adverse events were analysed descriptively, Parkinson's disease symptoms were documented using a questionnaire applied by the physicians. Patients were evaluated at study start and three and six months later, respectively. In 31 patients, 32 adverse events were observed, gastrointestinal and nervous system disorders being the most frequent. Dyskinesias, psychoses/hallucinations, sleep disturbances, and cardiovascular disorders were uncommon (< or = 1%). in total, 21 adverse events were classified as adverse drug reactions. In nearly 80 % of the cases, Parkinson symptoms had improved or completely vanished. Symptoms were unchanged in 16.7 % of patients and had worsened in 3.1%. The results confirm that the use of alpha-DHEC in combination therapy with levodopa in patients with Parkinson's disease is a well-tolerated and efficacious treatment option.


Asunto(s)
Antiparkinsonianos/uso terapéutico , Dihidroergocriptina/uso terapéutico , Enfermedad de Parkinson/tratamiento farmacológico , Anciano , Antiparkinsonianos/administración & dosificación , Antiparkinsonianos/efectos adversos , Dihidroergocriptina/administración & dosificación , Dihidroergocriptina/efectos adversos , Femenino , Trastornos Neurológicos de la Marcha/tratamiento farmacológico , Trastornos Neurológicos de la Marcha/etiología , Humanos , Levodopa/uso terapéutico , Masculino , Rigidez Muscular/tratamiento farmacológico , Rigidez Muscular/etiología , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/fisiopatología , Postura/fisiología , Desempeño Psicomotor/efectos de los fármacos , Desempeño Psicomotor/fisiología , Trastornos del Habla/tratamiento farmacológico , Trastornos del Habla/etiología , Temblor/tratamiento farmacológico , Temblor/etiología
13.
Arzneimittelforschung ; 52(10): 725-30, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12442634

RESUMEN

Nifuratel (CAS 4936-47-4) displays a strong antiprotozoarian and antibacterial activity and is provided with certain fungicidal effect, but it is not active against the physiologic flora. Its therapeutic effectiveness has been evaluated in more than 12,000 patients. The wide clinical experience with nifuratel confirms that the drug is safe and effective for the treatment of trichomoniasis, bacterial vaginosis, candidosis, and, particularly, in patients suffering from mixed vaginal infection. A meta-analysis of clinical trials comparing nifuratel and metronidazole (CAS 443-48-1) in vulvovaginal infections was performed. All parallel-group metronidazole-controlled trials carried out in patients with vulvovaginal infections have been included, complying with the following criteria: 1) cure assessed both as disappearance of symptoms and signs, and negative microbiological findings; 2) microbiological tests performed with valid methods still used in current practice. Seven clinical trials have been selected, including overall 1767 patients, 832 out of whom were treated with nifuratel and 935 with metronidazole. The results of the meta-analysis confirmed the equivalence between nifuratel and metronidazole: overall proportion of cured patients in the two groups were 88.5% and 90.0%, respectively, in the presence of homogeneity among studies (p = 0.342). In the fixed and random effect analyses, the confidence interval of Odds ratio included 1 and the p values for testing the hypothesis of no difference between treatments were 0.656-1.266, p = 0.582 (fixed effects) and 0.643-1.290, p = 0.599 (random effects), respectively, indicating equivalence. Furthermore, some controlled studies and the wide clinical experience showed that the cure rate of nifuratel in patients with mixed infections due to Trichomonas vaginalis + Candida or Trichomonas vaginalis + bacteria or with bacterial vaginosis and mixed bacterial flora is higher than that of metronidazole, due to the wide spectrum of action of nifuratel.


Asunto(s)
Antifúngicos/uso terapéutico , Antitricomonas/uso terapéutico , Nifuratel/uso terapéutico , Enfermedades Vaginales/tratamiento farmacológico , Antitricomonas/administración & dosificación , Antitricomonas/efectos adversos , Femenino , Humanos , Metronidazol/uso terapéutico , Nifuratel/administración & dosificación , Nifuratel/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto , Enfermedades Vaginales/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA